Dr. Stephanie Gaillard, MD
Claim this profileJohns Hopkins University/Sidney Kimmel Cancer Center
Studies Ovarian Cancer
Studies Cancer
9 reported clinical trials
20 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
MSI positive
dMMR positive
2Cancer
Stage IV
PIK3CA positive
MSI positive
Affiliated Hospitals
Clinical Trials Stephanie Gaillard, MD is currently running
Alpelisib + Fulvestrant
for Endometrial Cancer
This trial tests a combination of two drugs, alpelisib and fulvestrant, in patients with a specific type of endometrial cancer. These patients have a genetic mutation (PIK3CA) and their cancer grows in response to estrogen. Alpelisib targets the mutation, while fulvestrant blocks estrogen, aiming to stop cancer growth. Alpelisib is the first drug of its kind approved for use with fulvestrant based on its effectiveness in treating similar types of cancer.
Recruiting1 award Phase 210 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about Stephanie Gaillard, MD
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Stephanie Gaillard, MD has experience with
- Bevacizumab
- Alpelisib
- Fulvestrant
- Fostamatinib
- Paclitaxel
- TPST-1495
Breakdown of trials Stephanie Gaillard, MD has run
Ovarian Cancer
Cancer
Endometrial Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie Gaillard, MD specialize in?
Stephanie Gaillard, MD focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are MSI positive.
Is Stephanie Gaillard, MD currently recruiting for clinical trials?
Yes, Stephanie Gaillard, MD is currently recruiting for 5 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Stephanie Gaillard, MD has studied deeply?
Yes, Stephanie Gaillard, MD has studied treatments such as Bevacizumab, Alpelisib, Fulvestrant.
What is the best way to schedule an appointment with Stephanie Gaillard, MD?
Apply for one of the trials that Stephanie Gaillard, MD is conducting.
What is the office address of Stephanie Gaillard, MD?
The office of Stephanie Gaillard, MD is located at: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins University/Sidney Kimmel Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.